Become a Creator today!Start creating today - Share your story with the world!
Start for free
00:00:00
00:00:01
Mechanical Ventilation In COVID - 19
10 Plays6 years ago
On this episode of Critical Matters, we will focus on respiratory support and mechanical ventilation with COVID-19. Our guest is Dr. Luciano Gattinoni, a thought leader in the field of critical care. Dr. Gattinoni introduced the concept of lung rest by extracorporeal CO2 removal in acute respiratory failure. He pioneered the use of thoracic CT in ARDS, which culminated in the "baby lung", lung recruitability, and Mechanical Power concepts. His research is focused on the pathophysiology and treatment of acute respiratory failure, including prone positioning, sepsis and acid-based disorders. Dr. Gattinoni has published more than 400 research articles and reviews in peer-reviewed journals.
Additional Resources:
COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome: https://bit.ly/3e2cNNw
COVID-19 Pneumonia: Different Respiratory Treatment for Different Phenotypes?: https://bit.ly/2URaCFd
Books Mentioned in this Episode:
Siddharta by Herman Hess: https://amzn.to/3bXi6vP
The Prince by Nicolo Machiaveli: https://amzn.to/2RjyOho
Nunn's Applied Respiratory Physiology: https://amzn.to/2UQLeiX
The Pathway for Oxygen by M.D. Edwald R. Weibel: https://amzn.to/2yKpNrf
Clinical Physiology of Acid-Base and Electrolyte Disorders by Burton Rose and Theodore Post: https://amzn.to/3e2dDdh
Recommended
Transcript
Introduction to Critical Matters Podcast
00:00:06
Speaker
Welcome to Critical Matters, a sound critical care podcast covering a broad range of topics related to the practice of intensive care medicine.
00:00:14
Speaker
Sound Critical Care provides comprehensive critical care programs to hospitals across the country.
00:00:20
Speaker
To learn more about our programs and career opportunities, visit www.soundphysicians.com.
00:00:27
Speaker
And now, your host, Dr. Sergio Zanotti.
COVID-19 Pandemic Overview
00:00:32
Speaker
The COVID-19 pandemic continues to grow throughout the world.
00:00:36
Speaker
The United States has now become the epicenter of the pandemic with a rapidly growing number of cases and deaths.
Respiratory Support & Mechanical Ventilation
00:00:42
Speaker
Today's episode will focus on our discussion on respiratory support and mechanical ventilation with COVID-19.
00:00:48
Speaker
Recognizing that we still don't know enough about this disease and still unclear what would be helpful and what would be harmful, we thought that a discussion on what we've learned so far and how to apply these thoughts at the bedside would be timely.
Guest Introduction: Dr. Luciano Gattinoni
00:01:02
Speaker
Our guest is Dr. Luciano Gattinoni.
00:01:05
Speaker
a true thought leader in critical care.
00:01:07
Speaker
Dr. Gattinoni is Emeritus Professor of the University of Milan.
00:01:10
Speaker
He is currently working as a professor at the University of Göttingen in Germany.
00:01:15
Speaker
He introduced the concept of lung rest by extracorporeal CO2 removal and acute respiratory failure.
00:01:20
Speaker
He pioneered the use of thoracic CT and ARDS, which culminated in the baby lung, lung recruitability, and mechanical power concepts and theories.
00:01:29
Speaker
His research is focused on the pathophysiology and treatment of acute respiratory failure.
00:01:34
Speaker
including prone positioning, sepsis, and acid-base disorders.
00:01:38
Speaker
He has published more than 400 research articles and reviews in peer-reviewed journals.
00:01:42
Speaker
He has served as president of the European Society of Intensive Care Medicine, president of the World Federation of Societies of Intensive Care, Critical Care Medicine, and president of the Italian Society of Anesthesia, Analgesia, Reanimation, and Intensive Care.
00:01:55
Speaker
It's a true honor to have him as a guest.
00:01:57
Speaker
Luciano, welcome to Critical Matters.
Understanding Ventilator-Induced Lung Injury (VILI)
00:02:00
Speaker
Hi, everybody.
00:02:04
Speaker
So I think that we are definitely living unprecedented times in terms of this COVID-19 pandemic really affecting every single country in the world and being, I think, in the forefront of our colleague intensivist day in and day out now.
00:02:18
Speaker
And I think that one of the things that I've noticed is that there's also been an explosion of information, an infodemic with good and bad information.
00:02:28
Speaker
But one of the reasons why I reached out
00:02:31
Speaker
was because I had seen in a lot of forums people posting thoughts and recommendations attributed to you that then when I finally was able to read an opinion piece that you had put in the blue journal, it didn't seem to represent exactly what you were saying and thinking.
00:02:48
Speaker
But I do think that there are some very important lessons to learn about what we know about the lung disease that COVID-19 is producing.
00:02:57
Speaker
So, Luciano, maybe we could start with just a basic review
00:03:00
Speaker
of our understanding of ventilator-induced lung injury and lung protective ventilation.
00:03:04
Speaker
And maybe you could just give us like a very basic overview on Vili and how you think about barotrauma, volume trauma, stress strain, and we can start there.
00:03:15
Speaker
Okay.
00:03:16
Speaker
Well, you know, the ventilator-induced lung injury, as it's called now, has been recognized just after the initiation of the ventilation in mechanical ventilation.
00:03:29
Speaker
and was called barotrauma.
00:03:31
Speaker
Why barotrauma?
00:03:32
Speaker
Because about 50%, 60% of the patient had pneumothorax, pneumobiliacinam and so on.
00:03:40
Speaker
So the pressure used was up to 100 centimeters of water.
00:03:46
Speaker
Then with Dreyfus, this concept shifted from barotrauma to volotrauma because Dreyfus said, okay, if I wrap the thorax
00:03:59
Speaker
with an unelastic substance, so I impede the dilatation of the thorax.
00:04:06
Speaker
I can use whatever pressure I want, there is no problem.
00:04:10
Speaker
It's the concept of the divers.
00:04:11
Speaker
You go down with a lot of atmosphere, you can go to 10 atmosphere and the land does not explode.
00:04:18
Speaker
Because you have 10 atmosphere outside.
00:04:21
Speaker
But the concept evolved to stress and strain, and basically to make short and long story,
00:04:30
Speaker
The strain, which I think is the fundamental part of the business, is when the lung structure is stretched over a certain degree over his resting position.
00:04:45
Speaker
Resting position is a function of the residual capacity.
00:04:49
Speaker
If I add the PIP, I already strain in part the lung.
00:04:54
Speaker
If I add the tidal volume, I strain even more.
00:04:58
Speaker
And what it appears quite consistent is that when the strain goes over the total lung capacity, not just for one breath, but for several breaths, and maybe for one day or several hours, the lung, you've got the ventilator-induced lung injury, which manifests with what?
Strategies to Minimize VILI
00:05:21
Speaker
It manifests or with rupture, if you have a stress or strain or rupture,
00:05:26
Speaker
or with an inflammatory reaction, we cannot distinguish from the normal RDS, because you have inflammatory cells, edema, and so on.
00:05:37
Speaker
So, by the way, the last thing to remember is that the stress and strain are not distributed homogenous into the lung, but are particularly important in the lung region
00:05:54
Speaker
where the elasticity is different in these regions the stress and strain are concentrated because one ex one region or one structure expand more than the others this is called focused stress and is one of the problem of the non-homogeneity of the lung so basically the ventilator induced lung injury is
00:06:21
Speaker
A strain of the lung above is a physical capability, to which follows the rupture after days.
00:06:31
Speaker
But don't forget that within the lung there is one organ which is called heart.
00:06:37
Speaker
And we cannot speak about the lung if you do not consistently think to the immunodynamics.
00:06:43
Speaker
Because any time the lungs is hyperinflated or stressed, the heart,
00:06:49
Speaker
is compressed, disappear behind the vertebral column, the venous return decreases, the kidney starts to suffer, and so and so.
00:07:03
Speaker
So I think in the concept of VLE should be integrated also the concept of the immunodynamic involvement.
00:07:15
Speaker
So I think that to summarize,
00:07:17
Speaker
Yeah, to summarize for our listeners, Dr. Gattinoni, the stress really would be equivalent to the pressure, the transplural pressure, right?
00:07:28
Speaker
That's right.
00:07:28
Speaker
It's the transplural pressure which correspond to a given strain.
00:07:35
Speaker
You cannot strain the lung without applying a change in pressure.
00:07:41
Speaker
So these are two phases of the same medal.
00:07:46
Speaker
And the constant of proportionality between stress and strain is called specific elastance.
00:07:55
Speaker
So that means the transformatory pressure or stress is equal to K, which is specific elastance, times, let's see, tidal volume plus PIP volume divide the resting lung volume.
00:08:10
Speaker
This is the basic equation of stress and strain.
00:08:16
Speaker
So I think that one, I have two questions.
00:08:18
Speaker
And the first question is that it is evident that no matter what we are doing with a patient or whatever syndrome they have, if they're on mechanical ventilation, considering ways to minimize the injury from stress and strain obviously is something that would help them clinically, right, as a basic concept.
00:08:37
Speaker
That's right.
00:08:39
Speaker
But, you know, I think that if you want to approach a rational mechanical ventilation,
00:08:46
Speaker
you have to know which are the lung condition we start with.
00:08:51
Speaker
The ventilable lung is very small, we call it baby lung.
00:08:55
Speaker
It's very small in one thing.
00:08:57
Speaker
If you have a lung with a very large volume, it's another completely different thing.
00:09:03
Speaker
But the concept of stress and strain applied in both conditions.
00:09:08
Speaker
In one, you will have less volume to cause
00:09:12
Speaker
let's call harmful strain in the other condition, will be a larger tether volume when we start with a larger resting
Spontaneous Breathing vs. Mechanical Ventilation
00:09:22
Speaker
volume.
00:09:22
Speaker
Unfortunately, nobody measure the volume and nobody measure how much volume is due to PEEP.
00:09:31
Speaker
The PEEP is a pressure and rise up the lung volume.
00:09:35
Speaker
So it's easier with the tether volume, higher is the PEEP, it's easier to reach
00:09:42
Speaker
the total line capacity, which is the limit.
00:09:45
Speaker
You know, the literature is full of a protective effect of PEEP.
00:09:51
Speaker
But this protective effect of PEEP are due because the PEEP is high or because the tidal volume has been reduced.
00:10:00
Speaker
Because you don't see any protection when you rise the PEEP at the same tidal volume.
00:10:07
Speaker
At that point, it may be a disaster.
00:10:09
Speaker
Matthew, that's an important point because
00:10:12
Speaker
A lot of people assume that high PEEP, independently of what else you're doing, might work or might not work.
00:10:19
Speaker
And I think that you're saying everything is really connected.
00:10:23
Speaker
That's right.
00:10:24
Speaker
To me, I repeat, I'm not the true in the pocket, but to me, this is a very severe mistake to consider that.
00:10:37
Speaker
The PEEP is for the rest.
00:10:40
Speaker
The second question Luciano I have regarding this whole concept of stress and strain and Vili is what about people who are not on mechanical ventilation?
00:10:49
Speaker
Is there potential for lung injury by increasing stress and strain in somebody who has respiratory failure and is spontaneously breathing?
00:10:58
Speaker
That's right.
00:10:59
Speaker
Okay.
00:11:00
Speaker
Let me consider it.
00:11:02
Speaker
What does the mechanical ventilation?
00:11:05
Speaker
The mechanical ventilation substitute the respiratory muscle, right?
00:11:11
Speaker
does not substitute the gas exchange, just substitute the respiratory muscle.
00:11:18
Speaker
So, if instead of the energy provided by the ventilator, I provide a similar energy from the muscles, the question of stress and strain are exactly the same.
00:11:33
Speaker
Change the hemodynamic, but the stress and strain are exactly the same.
00:11:40
Speaker
In Ted Kolbov, well, in the 38s, Barak proved that very clearly.
00:11:48
Speaker
In 1988, Mascherone and Kolbov, Kolbov was always 20 years ahead of the rest of the world, were injecting some acetyl acid in the cisterna mania of the ship, so the ship started to have a very big tidal volume.
00:12:09
Speaker
has to have a very big mechanical ventilation.
00:12:12
Speaker
In 24 hours, this lag had ARDS, perfectly in spontaneous breathing, with inner weight pressure
Hyperprotective Ventilation Risks
00:12:22
Speaker
zero.
00:12:24
Speaker
But the transpulmonary pressure was huge.
00:12:27
Speaker
And now this concept has been rediscovered, revised, and so on by Brochard, Perzentia, Slaski, when they describe the patient
00:12:38
Speaker
self-inducted lung injury which is extremely important overall in this codic 19 pneumonia i think but you know the same transformer repression if it's harmful maybe it's exactly hard from exactly helpful in mechanical ventilation and in spontaneous breathing the big difference between the two is the hemodynamics
00:13:07
Speaker
With the spontaneous breathing, you suck the blood into the central system.
00:13:15
Speaker
With the mechanical ventilation, you squeeze out the blood from the mechanical system.
00:13:22
Speaker
Yeah.
00:13:23
Speaker
And I think that those are important concepts, like you said, that we'll touch a little bit later when we talk specifically about COVID-19.
00:13:28
Speaker
But I think that to close this first segment, Dr. Gattinoni, when I hear people talk about lung protective ventilation,
00:13:37
Speaker
I think that most clinicians at the bedside think of two things.
00:13:41
Speaker
They think of small tidal volume and they think of a plateau pressure below 30.
00:13:47
Speaker
That's kind of in their mind.
00:13:48
Speaker
And some people might think high PEEP, some people might think low PEEP, but that's kind of what people think.
00:13:52
Speaker
But really from what I'm hearing you talk about, lung protective ventilation not only applies maybe to mechanical ventilation, but applies to any patient we're supporting and really is about utilizing the tools we have available to minimize
00:14:08
Speaker
damage on the lung from stress and strain.
00:14:11
Speaker
Would that be an appropriate way of thinking about it?
00:14:14
Speaker
Absolutely.
00:14:15
Speaker
I think what you have to think, the people is not accustomed to measure the pleural pressures, unfortunately.
00:14:22
Speaker
But what counts is the pleural, the transpulmonary pressure, so the difference between airway and the outside of the pressure, which is equal to the stress.
00:14:33
Speaker
And then the basic concept applied equally.
00:14:38
Speaker
And the tidal volume of enterase is protective.
00:14:41
Speaker
Well, we have the magic six milliliters per kilo, which is better than 12.
00:14:46
Speaker
Not necessarily, it's better than eight.
00:14:49
Speaker
Dependence and the compliance the patient starts with, you know?
00:14:55
Speaker
And the second concept, be careful with the hyper, how they call it, hyperprotective.
00:15:03
Speaker
Because the people say, if six is better than 12,
00:15:07
Speaker
five would be better than six four better than five three better than two minus ten better than zero is not like that because if you go at a hyper protective ventilation with the c4 of people the four of uh televolume you look at the co2 because you have a risk of hyperventilation and hyperventilation even if you use co2 remover is hyperventilation that means
00:15:36
Speaker
the gas which arrive at the alveolar level are not enough.
00:15:42
Speaker
The oxygen consumed is much more than the oxygen transferred from the air to the alveoli.
00:15:49
Speaker
That means after a while, this unit undergo in reabsorption at the lectasis.
Mechanical Power in Ventilation
00:15:59
Speaker
So this is the intrinsic risk of the very low so-called hyperprotective.
00:16:07
Speaker
I think we should protect some time the lung from the doctors.
00:16:11
Speaker
I agree.
00:16:12
Speaker
And I think that also what people, I think, fail when they don't understand, when we walk away from understanding the basic physiology, is that on average, if you took thousands of patients, because of what we've discussed, 6 mLs is probably safer in reducing the strain and associated with a lower stress than 12 mLs.
00:16:34
Speaker
But that's an average.
00:16:37
Speaker
This is absolutely true.
00:16:40
Speaker
But remember to look always to the pCO2 because the pCO2 tell you the degree of a very ventilation we are dealing with.
00:16:51
Speaker
So the gas exchange is mathematics, you know.
00:16:54
Speaker
You have to consider all the variables at play, not just to oxygen or just the CO2 or just the frequency or just the
00:17:06
Speaker
We tried to introduce the concept of mechanical power in terms of VIRIT, which is the product is a variable which takes together the pressures, the volume, and the frequency.
00:17:21
Speaker
And what we found, at least experimentally, for a given damage is reached when you give a given package of mechanical power.
00:17:33
Speaker
Sometimes with lower total volume but very high frequency,
00:17:36
Speaker
It's just as bad as higher tidal volume with far lower frequency.
00:17:41
Speaker
Frequency is always for God.
00:17:43
Speaker
But if I have a bad tidal volume, 10 per minute, 20 per minute, or 40 per minute, make a tremendous difference.
00:17:55
Speaker
But the people does not consider this one.
00:17:59
Speaker
I think the mechanical power will gain some popularity.
00:18:02
Speaker
Not now, because now the people is busy with other things.
00:18:08
Speaker
Yeah, it's hard to apply it to a thousand patients at once, right?
00:18:12
Speaker
Absolutely, absolutely.
00:18:13
Speaker
But I think it's important, I mean, no matter what's going on, to always try to learn from what we're seeing so that tomorrow we could do things a little bit better.
00:18:22
Speaker
Okay, but I don't know.
00:18:24
Speaker
I think the mechanical power will be implemented in the ventilator.
00:18:28
Speaker
So, sooner or later, we come out one number, joule per minute, and you know what is the energy we're putting in the system.
00:18:35
Speaker
Because all the data, all the numbers are available in whatever modern ventilator.
00:18:44
Speaker
And I think that also the interesting concept, I mean, that you said, like, frequency is always forgotten.
00:18:49
Speaker
But I think that also applies to clinical scenarios that I've seen, for example, people struggling with non-invasive, with a respiratory rate in the
00:18:57
Speaker
high 30s and they kind of puddle along and probably causing tremendous amount of injury to their lungs.
00:19:03
Speaker
And then when they finally get intubated, we kind of wonder why they have such a bad outcome, right?
00:19:10
Speaker
You know, what I found terrible in non-invasive ventilation is that theoretically, the only difference you have with the invasive ventilation is the tube.
00:19:22
Speaker
But with the non-invasive ventilation,
00:19:25
Speaker
you don't know anything or what you are doing.
00:19:29
Speaker
You don't know even how much is the tidal volume you are delivering.
00:19:33
Speaker
You do not have an idea of the transpulmonary pressure the patient is generating.
00:19:40
Speaker
To me, using the mechanical ventilation, without the esophageal pressure, they tell me how much are the swings of the pleural pressure of the patient, is asked to drive during the night, in a foggy night,
00:19:55
Speaker
without knowing where to go, maybe in a forest.
00:20:00
Speaker
Very dangerous.
COVID-19 vs. Typical ARDS
00:20:02
Speaker
So let's talk a little bit about COVID-19 associated severe acute respiratory illness.
00:20:09
Speaker
And I think that one of the observations that you and your colleagues have made is that there might be things that appear to be similar to what we call ARDS, which is also a syndrome, like we all know.
00:20:22
Speaker
But there might be some things that
00:20:24
Speaker
appear to be different, and that might have implications in the way we should be thinking or approaching these patients.
00:20:30
Speaker
So maybe you could just start by giving us a summary of what we know so far, and then maybe talk about what is similar to ARDS, and more importantly, what is different to other forms of ARDS that we usually treat.
00:20:43
Speaker
Well, of course, I think I'm playing with ARDS since 40 years.
00:20:48
Speaker
But I never saw a classical ARDS, let's see, severe ARDS because this patient
00:20:54
Speaker
very often have a PF below 100, so they have an hypoxemia comparable with severe LDS.
00:21:03
Speaker
They have some ground less, so they have bilateral involvement of the lung, bilateral pneumonia, but the compliance is 60, 70, sometimes 80, in more than 50% of the patient when they do present.
00:21:22
Speaker
And I never saw something like that in never.
00:21:27
Speaker
Maybe it occurs one place, but really is extremely rare, I put it in this way, in a severe RDS.
00:21:36
Speaker
If you go to the Bellani, the SAFE study, you see that even the mild RDS, the compliance is always below 40.
00:21:47
Speaker
Goes from 40, 35, 30.
00:21:51
Speaker
Here we have a median and a mean greater than 50.
00:21:57
Speaker
So this is the fundamental basis to start with.
00:22:04
Speaker
We have to sit down and to say how this is possible.
00:22:09
Speaker
Then we have a lot of CT scan of the patients, which are done very rarely.
00:22:16
Speaker
And let me try to tell you
00:22:21
Speaker
The story, as I see the story which I collect, discuss with the nurses, with the colleagues from different hospitals in Nombardir and after studying and examining a lot of CT scan data coming from my colleagues.
00:22:41
Speaker
Have you five minutes of patience for that?
00:22:45
Speaker
Hello?
00:22:47
Speaker
Yes.
00:22:48
Speaker
Are you there?
00:22:48
Speaker
Okay.
00:22:50
Speaker
If we don't have the pathophysiology clear in mind, to speak about the treatment to me is nonsense.
00:22:59
Speaker
So, let's start in this way.
00:23:01
Speaker
The virus comes.
00:23:04
Speaker
What does the virus?
00:23:07
Speaker
While the bacteria affect mainly the alveolar size of the problem, we have consolidation capacity, the virus interferes primarily
00:23:19
Speaker
with the vessels and with the endothelial cells.
00:23:24
Speaker
So you have vasoplasia.
00:23:28
Speaker
Vasoplasia, what means?
00:23:30
Speaker
What means that the regulation of the blood through the lung is lost.
00:23:36
Speaker
If it's lost, where the blood tends to go, tends to go according to the gravity, which doesn't happen normally.
00:23:45
Speaker
We have quite homogenous distribution of blood.
00:23:48
Speaker
So we have, due to this vasoplasia, which may originate from endothelial stimulation and O and so on, for many, many reasons, possible reasons, you have a tremendous VAQ mismatch.
00:24:06
Speaker
VAQ mismatch is a rather complicated physiological concept, but very briefly means that if one part of the lung
00:24:17
Speaker
I have a lot of ventilation and very, very, very small perfusion.
COVID-19 Pathophysiology Insights
00:24:23
Speaker
In the other part of the lung, I have a small ventilation and very, very high perfusion.
00:24:32
Speaker
What is the final result?
00:24:34
Speaker
If you play with the models, you may have tremendous hypoxemia, even with 60, 70, 80% of shunt.
00:24:46
Speaker
And this hypoxemia at the beginning is very sensitive to oxygen.
00:24:51
Speaker
Now, when this patient is going to the hospital, we have several patients, and this is consistent observation throughout the world, that come with 60, 65 of oxygen saturation, that means 35 of PO2, and do not accuse anything else.
00:25:14
Speaker
but some fever are not disnoic.
00:25:17
Speaker
Why?
00:25:19
Speaker
Because when you have this kind of hypoxemia, which is due to the vasoplegia, the brain, our center reactor, activating, trying to increase the tidal volume, so increase the minute ventilation.
00:25:37
Speaker
Now, if you have a good compliance, if you increase the tidal volume, you don't have any Dysnear.
00:25:44
Speaker
Because you make an effort and you find that the air coming into the land is exactly what we expect for this kind of effort.
00:25:55
Speaker
Is this clear, this concept?
00:25:58
Speaker
Yes.
00:25:58
Speaker
This may happen when you have some effort.
00:26:03
Speaker
I expect some amount of air and I receive less.
00:26:07
Speaker
Now, let's see, I have a patient that comes three days later into the hospital.
00:26:14
Speaker
and he stays at home with these big breaths.
00:26:19
Speaker
Big breaths, what does that mean?
00:26:21
Speaker
It means a big shift of pleural pressure, big negative pressure.
00:26:29
Speaker
And so we are back to tidal volume and to self-inductive lung injury.
00:26:37
Speaker
If I have this, I start to have more blood, return blood into the lung,
00:26:44
Speaker
I have to filter more plasma and the lung becomes more heavy and so become more edematous.
00:26:54
Speaker
And the picture starts to resemble to RDS because the compliance goes down.
00:27:02
Speaker
And from 70 goes maybe to 50.
00:27:05
Speaker
Three days later is at 35.
00:27:08
Speaker
At this point, you are perfect picture of RDS.
00:27:13
Speaker
And you see this perfectly well, following the CT scan with these patients.
00:27:19
Speaker
You see exactly the transition from what we call L light status, that means low VQ, low elastance, low longwave, low edema, to the high status or high type, which is high elastance, which means low compliance, high volume, high
00:27:43
Speaker
lung weight etc etc so at this point i have some patient coming in the hospital which breathes normally without this name some patient coming this night some patient coming severely this night what they do have in common they are all hypoxemic because the hypoxemia is due to this tremendous vacuum mismatch
00:28:13
Speaker
At this point, if I have a lung which is full of gas, or a lung which is without a very small amount of gas and a lot of edema, would you use the same therapy?
Intubation Timing & Management in COVID-19
00:28:32
Speaker
Or in a lung full of gas, can you explain to me why to use 15 of PIP with a mask?
00:28:40
Speaker
One, look at the PO2.
00:28:41
Speaker
If I apply
00:28:43
Speaker
the PIP 502 table, you end up with 20 of PIP.
00:28:48
Speaker
With 20 of PIP, you kill this patient, not all, but a good amount.
00:28:55
Speaker
Just to tell you something that me impressed a lot.
00:28:59
Speaker
I was called a couple of days ago from an hospital in Switzerland.
00:29:05
Speaker
They had 40 patients with COVID.
00:29:12
Speaker
And they were applying.
00:29:14
Speaker
As soon as the chef went to see the inspiratory effort, that means the negative pressure of the CILI, he was taking immediately the patient in intensive care because they had a space for that.
00:29:30
Speaker
And he was putting in paralysis and mechanical ventilation.
00:29:35
Speaker
So reducing this tremendous possibility of VILI.
00:29:42
Speaker
40% of the patients all survived.
00:29:46
Speaker
In a hospital, 20 kilometres close to there, they were applying similar amount of patients.
00:29:54
Speaker
They were applying the suggested guideline.
00:29:59
Speaker
So, IPIP and then maybe delayed intubation and so on.
00:30:04
Speaker
The mortality was greater than 50%.
00:30:05
Speaker
In Athens,
00:30:11
Speaker
They told me the mortality was about 90%, applying the forms of ventilation that you apply in LDS.
00:30:22
Speaker
Then you tell me the patients were different, the ones were older, the comorbidities were different.
00:30:28
Speaker
But when you go from 0 to 50 to 90, I think we should, with extreme honest
00:30:39
Speaker
intellectual honesty, ask ourselves, are we doing something dramatically wrong?
00:30:47
Speaker
This is the first question.
00:30:49
Speaker
Before to say, no, this patient is different from mine because... Having said that, I think if I take a patient with 70 on compliance and I give a mask of non-invasive ventilation with 50, well, I have two possibilities.
00:31:07
Speaker
The idea would be to measure the inspiratory effort.
00:31:13
Speaker
But you can, okay, you don't have an esophageal balloon, you don't know how to use, okay.
00:31:18
Speaker
But look carefully.
00:31:21
Speaker
For one hour or two, what is the effort that the patient makes?
00:31:25
Speaker
If he start to use some respiratory accessory muscle, if he have some...
00:31:33
Speaker
ribs inflow, if you have a change in abdominal movement.
00:31:40
Speaker
If the patient is like this, you mean that it's continuing to induce a very big damage in his lung.
00:31:50
Speaker
At this point, I would suggest an immediate ventilation and paralysis.
00:31:57
Speaker
If the patient, very few, can support that, maybe you
00:32:02
Speaker
cut the visceral cycle because if the patient continues, it will get edema.
00:32:09
Speaker
If he got edema, he will have greater inspiratory effort to keep the tidal volume.
00:32:15
Speaker
And so you have a tremendous picture.
00:32:19
Speaker
So I think if the patient needs inspiratory effort associated with low oxygenation that does not respond to 5, 10, 15 or oxygen therapy,
00:32:32
Speaker
I think for what we know now to suggest immediate intubation and without any spontaneous movement of the patient.
Weaning COVID-19 Patients from Ventilators
00:32:44
Speaker
So, or deep sedation or paralysis.
00:32:48
Speaker
Of course, the patient will improve the PO2.
00:32:51
Speaker
What do you do when you start to see the PO2, which is good in the LDS?
00:32:56
Speaker
You start to win.
00:32:58
Speaker
If you do that with this patient after two days, you lose what you ever gave because this disease, disease not syndrome, requires time.
00:33:12
Speaker
And until the virus has not been eliminated by our antibodies or some miracle, you cannot win the patient.
00:33:24
Speaker
You just, the patient, start to breathe as hell
00:33:29
Speaker
and to have again dysmnea and then again edema and so on.
00:33:35
Speaker
So this depends to me, the therapy to be introduced depends on the phase that you see the patient and at what is the stage at the end.
00:33:49
Speaker
Although I do not have the ideal therapy, I know what is wrong.
00:33:53
Speaker
In this condition, it is easier to
00:33:58
Speaker
do mistake doing something then don't doing nothing you know sometimes i wonder if the patient comes perfectly okay with 70 of saturation and 14 of hemoglobin it's not different for the patient with neither saturation 95 a 10 of hemoglobin which is are used in intensive care i should put a very strange thing or just to be patient and to observe
00:34:28
Speaker
and to think at the physiology and to try to measure whatever is possible to measure i know that in front line is difficult but you don't have to lose the entire paradigm and i think that a couple of things i want to dive deeper in dr gatti noni number one is i think that something that that we're seeing across the country and in our group i mean we have cared for
00:34:56
Speaker
probably over 500 COVID critical care patients around the country.
Therapeutic Approaches & Drug Use in COVID-19
00:35:01
Speaker
And I think that that whole point that you made about patients is very important also as we're trying to extubate these patients.
00:35:08
Speaker
I think people are finding that if they extubate them too quickly, they often will get re-intubated.
00:35:15
Speaker
And I think it just applies to a very basic concept that I think I learned as a medical student.
00:35:21
Speaker
If it takes you eight days to get sick, it doesn't take you two days to get better, right?
00:35:26
Speaker
Absolutely.
00:35:27
Speaker
I mean, this pneumonia lasts at least 15 days.
00:35:32
Speaker
If you pretend to wait after five days, it's a disaster.
00:35:37
Speaker
Not only you have to wait to wait to the patient, but you have lost maybe 30% of the benefit you had before.
00:35:46
Speaker
And I know that to be patient, to do nothing is difficult in intensive care.
00:35:51
Speaker
Because in testic cancer, people are accustomed to, I turn it off, I see the result, I'm fast, quick, and rational.
00:35:59
Speaker
But in this case, to be rational, you have to be slow and quiet.
00:36:04
Speaker
Yeah.
00:36:06
Speaker
And I think it applies also to other therapies, and it's something I worry about.
00:36:11
Speaker
We've all been taught in medicine, first to no harm, primum non nocere.
00:36:16
Speaker
And I think that when you are dealing with thousands of patients,
00:36:21
Speaker
anything that potentially could be harmful gets magnified at such a level that I think it's extremely dangerous.
00:36:29
Speaker
And I think that people are very anxious.
00:36:32
Speaker
And like you said, they feel that doing something is always better than not doing something.
00:36:36
Speaker
And I think that not only in our discussion with mechanical ventilation, but with all these drugs that are experimental, there's no proof that they work.
00:36:43
Speaker
I also fear the same consequences.
00:36:45
Speaker
Let me lead to two words about the drugs.
00:36:47
Speaker
Now, unfortunately, this patient,
00:36:51
Speaker
and overall in emergency, go through infectivologists, pneumologists, or somebody that never saw one ventilator and acute respiratory failure, and they were given whatever, with one result, antivirus, chloroquine, anti-LA6, anti-L1, whatever.
00:37:16
Speaker
Okay, cortisone, yes, cortisone, no.
00:37:18
Speaker
The result with the antivirus,
00:37:21
Speaker
that you kill the liver and you don't kill the virus.
Anticoagulation Strategies for COVID-19
00:37:24
Speaker
And I'm not aware of any drug which is effective.
00:37:28
Speaker
I think that these people, we have to wait for them.
00:37:31
Speaker
We have to do the research and some studies, okay, this work or not.
00:37:36
Speaker
At the moment, I think the only thing that we can do is to provide nutrition, to keep the patient alive as more gentle as possible and pay, I forgot this,
00:37:49
Speaker
as this is a vessel endothelial disease, is probably one of the most pro-thrombotic situations you can observe in intensive care.
00:38:01
Speaker
That means the microtrombosis may be absolutely frequent and also some macrothrombosis as a pulmonary embolism or a brain damage with that.
00:38:19
Speaker
So I suggest, and look at the didymer.
00:38:22
Speaker
When the didymer is greater than 2000, we start with the prophylaxis as double as normal, and we start with the anticoagulation when the tendency of the didymer goes up.
Challenges of Spontaneous Breathing in COVID-19
00:38:36
Speaker
Believe me, this is an extremely important.
00:38:39
Speaker
I lost my friend, one friend of mine, 10 days ago, he was recovering from pneumonia and he got a stroke.
00:38:49
Speaker
And all the patients, all the people who did the autopsy, they did at least a report of 50 autopsies in Malaysia.
00:38:59
Speaker
They had endothelial cells flowing in the blood and a lot of micro thrombosis at the histological examination.
00:39:12
Speaker
And I think that obviously that goes into also the whole idea of the VQ mismatch that we started the discussion with and what happens in this early phase.
00:39:20
Speaker
Two more questions, Dr. Gattinoni.
00:39:23
Speaker
So these phenotypes of L and H, the low and high, some people have presented that as two distinct diseases.
00:39:32
Speaker
From what I understand, you're really thinking that is one, it's a progression, right?
00:39:37
Speaker
That's right.
00:39:38
Speaker
the one is the progression to the other.
00:39:40
Speaker
Sometimes the progression stops naturally, okay?
00:39:44
Speaker
And some patients stopped after the status L. Some patient progresses to the status H. I think that some therapy helped to progress from L to H because a wrong therapy would force the patient to have
00:40:05
Speaker
Too many effort compare what is allowed in this condition.
00:40:10
Speaker
But I think that the picture I put in this, I don't remember if in the editorial or in ECM editorial, is the same patient, seven days apart.
00:40:25
Speaker
And the seven days were CPAP, a lot of inspiratory effort, and very badly tolerated
00:40:34
Speaker
non-invasive ventilation.
00:40:35
Speaker
Yeah.
00:40:37
Speaker
And I think that we can go a little bit deeper into some of the treatments, but I think that early on, obviously, people have recognized that these patients are hypoxic, so the immediate reaction is you give them oxygen.
00:40:48
Speaker
And like you said, in many patients, that's enough, and the majority of patients do better.
00:40:53
Speaker
Now, as the oxygen requirements keeps going up, the next step in our usual approach to these patients is to escalate there and either use high-flow nasal cannula, high-flow oxygen,
00:41:04
Speaker
or in some people they would use non-invasive.
00:41:07
Speaker
And I think that people have been focusing on the non-invasive mostly as something to avoid because they're worried that that can increase the aerosolization of droplets and increase their risk of infection.
Risks of High-Flow Oxygen Therapy
00:41:18
Speaker
But really I think that the point here is that there's potential for more injury, there's potential for worse outcomes, and that has been suggested in some of the series.
00:41:31
Speaker
when you're making these pathophysiological observations, that makes sense.
00:41:34
Speaker
So it's not that you cannot use non-invasive, but if you use it within an hour, either it's better or it's a problem and you have to move to intubation.
00:41:42
Speaker
Is that the way to interpret?
00:41:44
Speaker
My suggestion is you can try, but limit the time, and please be extremely careful to the minimal sign of inspiratory effort the patient is made.
00:41:58
Speaker
The idea would be to put an esophageal pressure, but nobody put esophageal pressure in the peacetime.
00:42:06
Speaker
You can imagine the wartime.
00:42:07
Speaker
It's not practical.
00:42:11
Speaker
Okay, but you know, sometimes the people with a helicopter is more practical to put esophageal pressure inside.
00:42:20
Speaker
Anyway, to me, what we can do in terms of not harm is to
00:42:28
Speaker
avoid the patient in patient inflicted self-inflicted lung injury silly this way okay which is a real story so up whatever side that this patient may generate silly you have to intubate paralysis and keep for the time sufficient to heal
00:42:53
Speaker
What about high flow oxygen, Dr. Gattinoni, and the concept of dead space in these patients?
Non-Invasive Ventilation Concerns
00:43:00
Speaker
Well, you know, dead space, anytime you have a VAQ, the mass distribution, you have, of course, if you have low ventilation in one part, and high perfusion in the other part, I have high ventilation and low perfusion, which is read as dead space.
00:43:18
Speaker
Plus,
00:43:22
Speaker
There is also the possibility of microthrombosis.
00:43:25
Speaker
But remember, this patient at the beginning, I don't think they do have in general microthrombosis because they come with a PCO2 25, 30, 35.
00:43:38
Speaker
When the PCO2 goes up, that means that the structure of the lung starts to modify.
00:43:45
Speaker
I am far more afraid from the rise of PCO2 than from decrease of oxygen.
00:43:50
Speaker
because the PCO2 change reflects the structural change of the lung.
00:43:56
Speaker
Yeah.
00:43:57
Speaker
And I think that's also something analogous to what we've seen in ARDS.
00:44:02
Speaker
Patients can tolerate hypoxemia.
00:44:04
Speaker
I mean, you can go to the top of Everest and have a PO2 that's very low and come back down.
00:44:07
Speaker
You're not critically ill.
00:44:08
Speaker
But still, even in critically ill patients, we've seen that.
00:44:10
Speaker
But when you can't ventilate somebody, like you said, it reflects that there's been a change in the lung, and that's usually a very bad sign for that patient.
00:44:18
Speaker
Yes.
00:44:19
Speaker
Yes.
00:44:20
Speaker
So let's talk a little bit about how you would approach them once they get intubated.
00:44:25
Speaker
You talked early on, especially in this low phase, early on that you would obviously, deep sedation if possible, paralysis, make sure that you're looking at.
00:44:36
Speaker
In a patient which manifests some effort, okay?
00:44:42
Speaker
Because if the patient does not manifest any effort, maybe may tolerate easily.
00:44:49
Speaker
but this patient has to be observed carefully.
00:44:51
Speaker
The worst is that for reason of lack of beds, or for a lack of attention from the doctors and nurses, the patient stays two, three days having a big inspiratory effort in a spontaneous breathing or even in an invasive mechanical ventilation.
00:45:11
Speaker
This is the point.
00:45:13
Speaker
The motor is...
00:45:15
Speaker
the behavior of the pleural pressure swings that you don't see, but you have to imagine that do exist.
00:45:25
Speaker
Yeah, and I think that that's a good point that we have traditionally not really applied or thought about.
00:45:32
Speaker
And I think in terms of current recommendations, Dr. Gattinoni, I think that you could still fit these into a way, a rational way of approaching this.
Ventilation Strategies for COVID-19 Patients
00:45:41
Speaker
And I think that people recommend that we use
00:45:44
Speaker
lower tidal volumes in general four to eight doesn't mean that everybody should be six so for example if somebody has a good compliance maybe eight it's a perfectly you know for this patient if you have a compliance of eight in the patient who did a big start to big effort you have intubated the compliance is 65 i do use eight or you six look at the pco2
00:46:09
Speaker
if the pco2 go to 60 with 6 use 8 or even 9. look at the plateau pressure will be far from b30 the plateau pressure will be 22 23 with the people 7 8 because you don't require any big people to correct a little bit the distribution of the blood remember you don't have any recruitability in the health patient
00:46:36
Speaker
and you have some recruitability not tremendous in age patient.
00:46:42
Speaker
You know what it seems to me?
00:46:44
Speaker
I don't have patient enough, but in a patient which look in the sequence in the CT, maybe they start L, they become H. When they start to recover from H status, you see that the big consolidation in the dependent region decrease, and you see back still,
00:47:06
Speaker
the ground glass.
00:47:08
Speaker
So you see the virus behind that.
00:47:11
Speaker
It's very interesting, you know.
00:47:14
Speaker
Not laser.
00:47:16
Speaker
Yeah, yeah.
00:47:17
Speaker
It's tough because of the numbers, but like you said, I mean, there's always an opportunity to learn and understand also that people want dogma and want an answer.
00:47:27
Speaker
Give me a formula that I can apply to everybody and they'll be saved.
00:47:30
Speaker
And I think that that type of magical thinking is very dangerous.
00:47:35
Speaker
Yes.
00:47:36
Speaker
I'm afraid it's very dangerous.
00:47:39
Speaker
I mean, tell me why do I need a doctor if I have to do medicine in that way?
00:47:45
Speaker
And tell me why I should use a standard therapy, let's see, for an unstandard situation.
00:47:56
Speaker
Why I have to use gasoline for a car which goes with diesel?
00:48:02
Speaker
I'm afraid of the car.
00:48:05
Speaker
Dr. Gattinoni, so I think that in terms of, I think the tidal volume, like you said, look at the compliance, look at the effort, very important, look at the plateau pressure, all those things I think people have recognized.
00:48:16
Speaker
What about the PEEP?
00:48:17
Speaker
Would you think that the way to really, the way I've always thought about PEEP is use the least amount of PEEP that you need.
00:48:24
Speaker
Is that still true?
00:48:26
Speaker
Stay in that line, which is perfect.
00:48:30
Speaker
The minimal amount of PEEP that you need.
00:48:33
Speaker
In this patient, in a patient, I think you can run easily with seven, eight of people without any problem.
Role of PEEP in COVID-19 Treatment
00:48:42
Speaker
Because when I told you the compliance we measure, all the compliance, 78, were measured at five of people.
00:48:52
Speaker
So in standard condition when we measure that.
00:48:56
Speaker
Interesting.
00:48:57
Speaker
So I don't see any reason to have
00:49:00
Speaker
15 of people, and I know that this may be a disaster.
00:49:05
Speaker
And any time you play with people, and I know that very few do that, look at the heart function or look at the echo where you increase people, look at the right heart with the echo and see what's happened immediately.
00:49:21
Speaker
Or take a venous blood and look at VO2.
00:49:25
Speaker
Or look at how goes the plateau pressure.
00:49:29
Speaker
Increase PEEP, keeping the tidal volume.
00:49:32
Speaker
The pressure rise as I rise the PEEP, rise more or rise less?
00:49:38
Speaker
Can you have an idea what's going on?
00:49:42
Speaker
And then set the minimum.
00:49:44
Speaker
And I think that that's an important concept.
00:49:47
Speaker
You're not saying don't use PEEP, you're saying use the minimum amount of PEEP because as you go to the H phase and you might have more recruitability and more like an ARDS picture, you might need a little bit, you might need higher PEEP, right?
00:49:58
Speaker
You may need a higher PIP.
00:50:00
Speaker
And the best thing is to make a test and to measure.
00:50:05
Speaker
Because also in this one, you don't have it.
00:50:09
Speaker
We never observed so far spectacular recruitability.
00:50:14
Speaker
I say recruitability, not spectacular increase of oxygen.
00:50:18
Speaker
Because it is an oxygen is another thing than the recruitability.
00:50:23
Speaker
The oxygen may increase without any recruitability.
00:50:28
Speaker
as in air patient.
00:50:30
Speaker
The option is increasing proposition or with some people and so on, not because of the accountability, but because of a flow diversion.
Evaluation of Prone Positioning
00:50:40
Speaker
The flow goes in areas in which the VAQ is more favorable.
00:50:47
Speaker
That's it.
00:50:48
Speaker
So let me ask you, since you mentioned about propositioning, that's been, I think, recommended and a lot of people who have done it, including myself, have seen it.
00:50:57
Speaker
Basically, you have a response, but it's not as the response requires proning for longer periods of times, which goes along with two observations you've made.
00:51:06
Speaker
One is that this is a slow process in improving, and two, that perhaps the benefits of prone positioning are related to redistribution of blood.
00:51:14
Speaker
So obviously, when you put them back, that redistribution changes again, and you have to prone them again.
00:51:20
Speaker
But you think that prone positioning, I mean, because of that mechanism, if it works, I mean, might be something to think about.
00:51:27
Speaker
Well, I think as a rescue maneuver you can use.
00:51:31
Speaker
You don't have anyway big damages with prone position.
00:51:36
Speaker
Even it lacks in health patient the prerequisite to really be effective, which are the better distribution of stress strain.
00:51:46
Speaker
But consider also that you have a lot of patients.
00:51:50
Speaker
Having 20 patients, 25 patients in prone position may stress the nurses
00:51:57
Speaker
at a degree which you may avoid.
00:51:59
Speaker
Why?
00:52:01
Speaker
In patient, in the age patient, I think the proposition is absolutely correct.
00:52:09
Speaker
Because proposition basically makes less dangerous whatever thing you do to the lung.
00:52:17
Speaker
So, is there some form of protection, the proposition?
00:52:21
Speaker
I would use it as a therapy in
00:52:27
Speaker
in age patients, I would use as a rescue also to save the nurses in the L patients.
00:52:37
Speaker
And what about people have proposed, and I've seen in some patients with ABGs, non-intubated patients who, I mean, can self-prone or cooperative proning, and just telling them, sleep on your belly, I mean, when you can.
00:52:53
Speaker
and checking the gases and seeing amino change.
00:52:55
Speaker
Obviously, it has to do probably with redistribution of the blood.
00:52:57
Speaker
But any thoughts on that?
00:53:00
Speaker
Well, no, we have some of my colleagues who have studied this problem, put it dirty and so on.
00:53:09
Speaker
So somebody will come out.
00:53:11
Speaker
My suggestion, ask the patient.
00:53:15
Speaker
Ask the patient, do you feel better in this position or in that position?
00:53:20
Speaker
It's very simple.
00:53:21
Speaker
It's not intubated, it's conscious, and it can tell you perfectly.
Steroid Use in COVID-19 Treatment
00:53:25
Speaker
Some colleague of mine told me that the patient said, oh, okay, I'm much better in this position.
00:53:32
Speaker
Some other patients say, no, I prefer the semi-requimbing position to the supine.
00:53:37
Speaker
Some patients increase in the supine position the PO2.
00:53:42
Speaker
The problem is that when you lose our regulation of blood,
00:53:48
Speaker
The blood follows the gravity, I don't know what, but it depends how the lung is compromised.
00:53:55
Speaker
And the blood goes to the gravity.
00:53:57
Speaker
But it's an interesting thing to study.
00:54:00
Speaker
Anyway, in prone position, usually the oxygenation goes up, at least for the first four or five days.
00:54:08
Speaker
Then the response for oxygenation becomes lower.
00:54:12
Speaker
In a patient non-intubated,
00:54:14
Speaker
I would put in proposition if the patient are very hypoxemic and maybe even overall have dyspnoacality or start with some dysnare waiting for the bed and the intubation, I would ask the patient because the patient is the better judge of his condition, I think, in this situation.
00:54:39
Speaker
He breathes better or not.
00:54:41
Speaker
Yeah.
00:54:42
Speaker
And in terms of steroids, I think that clearly for the L phase, I mean, probably the data would say don't use it in everybody.
00:54:52
Speaker
But now I think that some people have concerns with the effect it might have on viral pneumonias with prolonged viral shedding and replication.
00:55:00
Speaker
What are your thoughts, Dr. Catinoni?
00:55:01
Speaker
Let's see.
00:55:06
Speaker
I don't want to give you the impression that from LH is just due to the doctors and so on.
00:55:15
Speaker
You may go from LH probably, even with what we call, what you think is the best treatment, because of the aggressivity of the virus and the host response.
00:55:29
Speaker
As everything starts with a reaction in the endothelial
00:55:35
Speaker
and with some cytokine storm.
00:55:38
Speaker
I have several colonists who start to measure the cytokine.
00:55:42
Speaker
All the inflammatory cytokine goes up.
00:55:45
Speaker
The anti-inflammatory cytokine in some patients are close to zero, in some patients are activated.
00:55:52
Speaker
But I think if the logic of steroids and so on is to decrease the progress, the over-inflammation, I would use at the beginning more than at the end.
Ethical Challenges of Ventilator Shortages
00:56:06
Speaker
I would use in L phase to prevent a possible transit to the H phase.
00:56:13
Speaker
But I don't have any, really any answer because in my life I saw the steroids coming in and coming out so many times in 40 years that I stopped to believe to them.
00:56:29
Speaker
Yeah.
00:56:30
Speaker
So I think that theoretically, I mean, that would be the argument, but like you said, I mean,
00:56:34
Speaker
So far, we have not been able to show that really we should or shouldn't.
00:56:38
Speaker
I have an adult response.
00:56:40
Speaker
If you see the patient, I think with 80 milligrams of prednisone, you didn't carry the body.
00:56:46
Speaker
Okay.
00:56:47
Speaker
And so I think in some situation, I would not hesitate to try.
00:56:53
Speaker
So we don't have to be so dogmatic because there is some rationale.
00:56:58
Speaker
I think if the patient is six to six,
00:57:01
Speaker
mechanical ventilation with 35 of peak 60 pco2 etc etc you may give the steroids but it's just for you not for the patient exactly and the last thing i wanted to ask you about treatment and then we'll wrap up and i'm very thankful for your time and generosity with all your your thoughts it relates to uh obviously concerns about um lack of ventilators or potential
00:57:29
Speaker
shortfalls in the numbers of ventilators.
00:57:31
Speaker
I mean, I know that there was a lot of talk about that in Italy.
00:57:33
Speaker
Now it's occurring in New York and in the United States.
00:57:36
Speaker
And I don't want to get into the ethical aspect.
00:57:38
Speaker
I think that's a conversation for a whole episode.
00:57:41
Speaker
But what about the thoughts of having more than one patient on one ventilator?
00:57:46
Speaker
It just seems that with a lot of things that we discussed and the potential for harm, that could be a very bad idea.
00:57:52
Speaker
Well, I think that if one ventilator lets see,
00:57:56
Speaker
you have the chance to kill one patient 50%.
00:58:00
Speaker
With two ventilators, I think the chance to kill two patients are 70%.
00:58:06
Speaker
Because all you know the physiology and the mechanical engineer so good that you use just the force of the ventilator for that.
00:58:19
Speaker
And you perfectly regulate the resistances, the diameter, the calibre.
00:58:25
Speaker
You choose the patient with a perfect, similar compliance characteristic.
00:58:31
Speaker
But during the war, this does not work, I think.
00:58:36
Speaker
So I think the double ventilator was, I think, patented 20 years ago in the States.
00:58:43
Speaker
But I think really is not medicine to me.
Advocacy for Simplicity in Ventilation Protocols
00:58:50
Speaker
Altura, that Kamar, Brody, so very distinguished.
00:58:55
Speaker
And very, very dear colleagues, they say, no, if you do the good protocol, good.
00:59:02
Speaker
But try to imagine how to win the patient in double ventilation.
00:59:07
Speaker
Until you put the patient and keep paralyzed, you are just sitting, and you do like this, okay, maybe you can survive.
00:59:14
Speaker
But when you have to follow all the course of the disease, it's very complicated.
00:59:21
Speaker
I think that's important because, like I said, I think with the anxiety that people have, everything that's new and different sounds like that's what we should be doing.
00:59:30
Speaker
And I think that people obviously are not thinking, what are the things that we understand?
00:59:36
Speaker
What are the things that we can apply and how can we first avoid doing more harm?
00:59:41
Speaker
But you know, by the way, it's not really so complicated.
00:59:45
Speaker
Because let's see, once we have decided to put a patient that's late, you put a sedation.
00:59:52
Speaker
Paralyzed.
00:59:53
Speaker
They avoid spontaneous breathing.
00:59:55
Speaker
Put eight to 10 people after checking the hemodynamics and don't do absolutely nothing for 10 days.
01:00:05
Speaker
But the usual, of course, the usual care.
01:00:09
Speaker
There is nothing to do.
01:00:11
Speaker
This sometimes is the problem.
01:00:14
Speaker
Nothing to do.
01:00:16
Speaker
Please don't go, oh, I have to win.
01:00:19
Speaker
Ballooning, you don't have to win anybody at the moment.
01:00:22
Speaker
because you make a disaster.
01:00:24
Speaker
I have to change the FiO2 and the change.
01:00:26
Speaker
No, don't do it.
01:00:29
Speaker
Leave the patient in peace until the body wins the virus.
01:00:37
Speaker
What you do may be more dangerous than what you don't do.
01:00:42
Speaker
And when you multiply
Closing Remarks on COVID-19 Management
01:00:43
Speaker
that by the numbers that we're seeing, obviously the potential for harm raises exponentially, which is some of the things that I always worry about.
01:00:51
Speaker
Yes, yes.
01:00:53
Speaker
Well, Dr. Gattinoni, go ahead.
01:00:56
Speaker
No, no.
01:00:57
Speaker
Just one consideration that I already did with another one.
01:01:02
Speaker
I think it's very irritating somebody to hear somebody that's saying, as I do now, do this, do that, suggest that, sitting in the office, relax with some water to drink, have a good time outside.
01:01:21
Speaker
But believe me,
01:01:22
Speaker
You are in front line.
01:01:25
Speaker
In front line, sometimes it's very difficult to see the course of all the battles, which is easier when you collect a lot of information from different sources to make a story.
01:01:41
Speaker
So the story I told you is not just from one or two people.
01:01:47
Speaker
It is collected from several colleagues.
01:01:51
Speaker
And I didn't find anybody until today that told me, no, the patients described are completely different from what we have seen.
01:02:03
Speaker
Everybody sees exactly the same patient.
01:02:06
Speaker
Depends the difference sometimes at the timing at which you see them.
01:02:13
Speaker
Therefore, it's fundamental to have an idea of the timing of the course of this damn disease.
01:02:22
Speaker
which is under the umbrella of RDS, but to me, well, to call it RDS is difficult.
01:02:30
Speaker
But let's call it as you want.
01:02:31
Speaker
There's no problem.
01:02:33
Speaker
Yep.
01:02:34
Speaker
I think that's important.
01:02:36
Speaker
And like I said, I really appreciate your time.
01:02:39
Speaker
We traditionally close the podcast with a couple of questions that are unrelated to the topic that I think that what I found is that even in those, these very difficult times where people are very focused on
01:02:50
Speaker
a lot of what has not happened yet and trying to figure out how to deal with things.
01:02:54
Speaker
Routine, I think, is always a good anchor to kind of bring us back to center.
01:02:59
Speaker
So would that be okay, Dr. Gattinoni?
01:03:02
Speaker
Okay.
01:03:03
Speaker
So the first question relates to books.
01:03:05
Speaker
And is there a book or books that have influenced you the most or that you have gifted most often to others?
01:03:11
Speaker
Well, a good question.
01:03:13
Speaker
Well, there are several, I'm afraid.
01:03:15
Speaker
But the first that will occur in my mind is Siddhartha,
01:03:19
Speaker
by Herman Hesse and The Prince from Machiavelli, which is an unbelievably great book.
01:03:27
Speaker
If you want to be a chief, read The Prince.
01:03:31
Speaker
And I think that one of them really focused on finding yourself and the other one on dealing with others.
01:03:38
Speaker
But I think it's a very nice combination, so we'll definitely put those in the show notes.
01:03:43
Speaker
The second question relates to what do you believe to be true in medicine
01:03:48
Speaker
or in life that most other people don't believe?
01:03:51
Speaker
And I think that the whole conversation has really centered around one of those things, but I'll let you answer it anyway.
01:03:57
Speaker
That's right.
01:03:59
Speaker
I think that what is true in medicine is pathophysiology and physiology.
01:04:08
Speaker
And a lot of people do not, it's not that they do not believe, but they do not know, which is even worse.
01:04:16
Speaker
Yeah.
01:04:17
Speaker
I think that that is something true that we see, I mean, a lot of colleagues in terms of how they apply not only these concepts but also, unfortunately, how they interpret what's published, right?
01:04:28
Speaker
It's not evidence-based, it's just reference-based and anything that's published in social media seems to have the same weight as a peer review article in a high-impact journal.
01:04:40
Speaker
What would you want every intensive is to know?
01:04:44
Speaker
Oh my God.
01:04:48
Speaker
I think I would suggest to read three books, which are books of mono-autors.
01:04:59
Speaker
One is Respiratory Applied Physiology by NUN.
01:05:04
Speaker
The second is The Pathway for Oxygen, Viable, Function and Anatomy.
01:05:12
Speaker
The third one is Acid-based and Electrolyzed Equilibrium
01:05:16
Speaker
by rose all mono author all the view of the same brain in a big problem i don't like the books which are the collection of several authors i prefer to read the soul of one single author in a single issue these make my life different these three books in terms of profession
01:05:46
Speaker
So we will definitely link those to the show notes.
01:05:50
Speaker
Dr. Gattinoni, thank you so much for your time and for sharing with us your thoughts.
01:05:54
Speaker
I think that definitely a lot of wisdom and a lot of actionable things here for our audience.
01:06:00
Speaker
I hope you stay safe and that we have a chance to talk again soon and hopefully maybe even see you next year, maybe in a conference in Mexico City.
01:06:09
Speaker
You be careful because at the moment are you more exposed to the problem.
01:06:15
Speaker
but remember that the people we end up with age status are probably one over 500 of over 1 000. so the chances are are very low but you have to know it okay absolutely thank you very much
01:06:35
Speaker
Thank you for listening to Critical Matters, a Sound Critical Care podcast.
01:06:40
Speaker
Make sure to subscribe to Critical Matters on Apple or Google Podcasts and share with your network.
01:06:46
Speaker
Sound Critical Care is transforming the way critical care is provided in hospitals across the country.
01:06:51
Speaker
To learn more, visit www.soundphysicians.com.